Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$892.5K
13.06K shares
What this filing means
MOTTIWALA AZIZ plans to sell 13.06K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $892.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/19/2026ACC: 0001959173-26-002521
Officer· Chief Commercial Officer
Since Oct 2020
13.06K
Shares to sell
$892.5K
Approx. market value
4.44K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/18/2026
4.44KTotal acquired4.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/18/2026 | Restricted Stock Vesting Compensation | 4.44K | — |
| Total | 4.44K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.33K
Market value
$297.5K
3/18/2026
—Completed
Units to sell
4.29K
Market value
$297.5K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.44K
Market value
$297.5K
3/19/2026
Total
Units
13.06K
Value
$892.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/18/2026 | 4.33K | $297.5K | — | Completed |
3/17/2026 | 4.29K | $297.5K | — | Completed |
| Planned — Approximate Date | ||||
3/19/2026 | 4.44K | $297.5K | NASDAQ | Planned |
| Total | 13.06K | $892.5K | ||